Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             166 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A37 Accounting for missing data in clinical trials of blood pressure (BP) and hypertension Cook, Nancy R.
1996
17 2S1 p. S59-S60
2 p.
artikel
2 A55 Adapting batch cleaning methods for lymphocyte data to on-line validation routines Carrington, Jane
1996
17 2S1 p. S70-
1 p.
artikel
3 A08 A data manager training program for oncology clinical trials Casagrande, Chris
1996
17 2S1 p. S42-
1 p.
artikel
4 A75 Adherence/compliance in a hormone replacement trial: The postmenopausal estrogen/progestins intervention (PEPI) trial perspective Hogan, Patricia
1996
17 2S1 p. S82-
1 p.
artikel
5 A89 A dynamic approach to recruiting patients in a registry of coronary interventions Holubkov, Richard
1996
17 2S1 p. S90-
1 p.
artikel
6 A74 A method to maintain blinding in a randomized trial requiring adjustment of doses for only one treatment arm Mercier, Catherine
1996
17 2S1 p. S81-
1 p.
artikel
7 A23 analysis by intention to treat in randomized clinical trials: A survey of the literature Jansen-McWilliams, Linda
1996
17 2S1 p. S51-
1 p.
artikel
8 A39 Analysis of agreement data beyond kappa: Application of loglinear modeling to evaluate agreement in disc photograph gradings Hussein, M.E.
1996
17 2S1 p. S60-S61
2 p.
artikel
9 A40 Analytical issues for Stroke clinical trials Tilley, Barbara C.
1996
17 2S1 p. S61-
1 p.
artikel
10 A59 An extension of stochastic curtailment for incompletely reported and classified data on recurrent outcomes: The multicenter study of hydroxyurea in sickle cell anemia (MSH) McMahon, Robert P.
1996
17 2S1 p. S72-
1 p.
artikel
11 A70 An inexpensive electronic system for handling adverse event reports Wong, Kenneth
1996
17 2S1 p. S79-
1 p.
artikel
12 A52 An interactive voice response system for randomizing patients Assmann, Susan F.
1996
17 2S1 p. S68-S69
2 p.
artikel
13 A29 A program for large, simple randomized clinical trials — American style Hillis, Argye
1996
17 2S1 p. S55-
1 p.
artikel
14 A49 Ascertainment of the primary end point in the multicenter study of hydroxyurea in sickle cell anemia (MSH) Barton, F.
1996
17 2S1 p. S67-
1 p.
artikel
15 A72 Automatic forms processing with Windows 95: Hyperbole? Wong, Kenneth
1996
17 2S1 p. S80-
1 p.
artikel
16 A34 Clinical monitoring of rating scales in multicenter clinical trials Schafer, Kimberly
1996
17 2S1 p. S57-S58
2 p.
artikel
17 A35 Clinical trial Monitoring in the face of changing clinical practice Thom, Elizabeth
1996
17 2S1 p. S58-S59
2 p.
artikel
18 A43 Collection of health care cost data in a VA health services study (CSHS#17) Cramer, Joyce
1996
17 2S1 p. S63-
1 p.
artikel
19 A26 Combining parallel trials with differing eligibility criteria Fowler, Sarah
1996
17 2S1 p. S52-S53
2 p.
artikel
20 A73 Comparability of self-report, pill count, and electronically monitored adherence data Dunbar-Jacob, Jacqueline
1996
17 2S1 p. S80-S81
2 p.
artikel
21 A32 computer-aided clinical monitoring: Results of a controlled experiment Thomas, Ronald G.
1996
17 2S1 p. S56-S57
2 p.
artikel
22 A03 Computing power in the design of clinical trials using ordered polychotomous logistic regression Ernesto, Christopher
1996
17 2S1 p. S39-
1 p.
artikel
23 A20 Concurrent medication tracking in an oracle database in the African American Study of Kidney Disease and Hypertension Stewart, Ron
1996
17 2S1 p. S49-
1 p.
artikel
24 A58 Consequences of data delay in a collaborative international sequentially monitored phase III prophylaxis trial Hurwitz, Shelley
1996
17 2S1 p. S71-S72
2 p.
artikel
25 A71 Datafax and data quality in a large, multi-center, clinical trial Krause-Steinrauf, Heidi
1996
17 2S1 p. S79-S80
2 p.
artikel
26 A80 Design of Phase II clinical trials incorporating response and early progression Zee, Benny
1996
17 2S1 p. S85-
1 p.
artikel
27 A83 Design of the NIDCD/VA hearing aid trial Henderson, William G.
1996
17 2S1 p. S86-S87
2 p.
artikel
28 A81 Diabetes prevention trial — type I (DPT-1) — design and implementation Rafkin-Mervis, Lisa
1996
17 2S1 p. S85-S86
2 p.
artikel
29 A47 Differences in endpoint identification by investigators versus independent review Tardiff, Barbara E.
1996
17 2S1 p. S65-S66
2 p.
artikel
30 A67 Double versus quadruple data entry Maupas, Jean
1996
17 2S1 p. S77-
1 p.
artikel
31 A42 Economic evaluation alongside clinical trials: A problem or a solution? Haider, Seema
1996
17 2S1 p. S62-
1 p.
artikel
32 A31 Ethical cost when the therapy target population and the dissemination population do not coincide Boissel, Jean-Pierre
1996
17 2S1 p. S56-
1 p.
artikel
33 A02 Evaluation of phase I cancer clinical trial designs Ahn, Chul
1996
17 2S1 p. S38-
1 p.
artikel
34 A09 Experience with interactive data management (IDM) in a Department of Veterans Affairs multi-center randomized clinical trial Sacks, Jerome M.
1996
17 2S1 p. S42-S43
2 p.
artikel
35 A13 Exploring the information superhighway: Use of the internet in clinical drug trials Carr, Sarah
1996
17 2S1 p. S44-S45
2 p.
artikel
36 A84 Extending intent-to-treat principles to cluster design clinical trials Hirst, Kathryn
1996
17 2S1 p. S87-
1 p.
artikel
37 A36 Facilitating the quality assurance process of data collected during the research interview Fischbach, Heidi E.
1996
17 2S1 p. S59-
1 p.
artikel
38 A69 Feasibility of keying data from screen-displayed facsimile images in the Collaborative Ocular Melanoma Study Diener-West, Marie
1996
17 2S1 p. S78-
1 p.
artikel
39 A17 Format-independent data collection forms, the world-wide web, and reusable research data management: A proposal Singer, Stephen W.
1996
17 2S1 p. S47-
1 p.
artikel
40 A21 graphical representation of symptom and concomitant treatment relationships Visèle, Nathalie
1996
17 2S1 p. S49-S50
2 p.
artikel
41 A28 Impact of continuing education on general practitioners' behaviour: Methodological problems Brun, Catherine
1996
17 2S1 p. S54-
1 p.
artikel
42 A30 Impact of the results of a trial on medical practice: Opinion survey among participating doctors Blondel, Béatrice
1996
17 2S1 p. S55-
1 p.
artikel
43 A79 Innovative trial design solutions to problemsposed by a randomized,multinational, double-blindphase III study of cytomegalovirus prohylaxis in AIDS patients Feinberg, Judith
1996
17 2S1 p. S84-
1 p.
artikel
44 A62 Issues in implementing a multi-centre, placebo controlled sequential design trialof anti-emetic prophylaxis (AEP)inpatients (pts) receiving radiotherapy (R) Palmer, Michael J.
1996
17 2S1 p. S73-S74
2 p.
artikel
45 A78 Issues in monitoring adherence to protocol using timed urine collections: Methods for assessing the adequacy of urine samples McFarlane, Mary
1996
17 2S1 p. S83-S84
2 p.
artikel
46 A24 Is the inclusion of the elderly in cancer and cardiovascular clinical trials increasing? Davidson, Michael
1996
17 2S1 p. S51-S52
2 p.
artikel
47 A61 Likelihood analysis of sequential trials Blume, Jeffrey
1996
17 2S1 p. S73-
1 p.
artikel
48 A50 Local versus central readings of endometrial biopsies in a multicenter clinical trial Legault, Claudine
1996
17 2S1 p. S67-S68
2 p.
artikel
49 A63 Managing a blinded 9000-patient coumadin clinic using express mail and facsimile Berdan, Lisa G.
1996
17 2S1 p. S74-
1 p.
artikel
50 A41 Methodological issues regarding variance estimation in cost evaluation Ducruet, Thierry
1996
17 2S1 p. S61-S62
2 p.
artikel
51 A22 Methodological quality in randomized trials and statistical heterogeneity in meta-analyses Schulz, Kenneth F.
1996
17 2S1 p. S50-S51
2 p.
artikel
52 A77 Modeling the association between compliance and response to treatment in primary prevention trials of cholesterol lowering drugs Norrie, John
1996
17 2S1 p. S83-
1 p.
artikel
53 A64 Number of lines for telephone randomization Kalish, Leslie A.
1996
17 2S1 p. S75-
1 p.
artikel
54 A46 Patient self-addressed postcard follow-up is inadequate: Results from the Duke Clinical Research Institute Mahaffey, Kenneth W.
1996
17 2S1 p. S64-S65
2 p.
artikel
55 A66 Personnel certification and turnover in the collaborative ocular melanoma study Church, Renée Y.
1996
17 2S1 p. S76-S77
2 p.
artikel
56 A15 Pilot-recruitment study for osteoporosis trial: Direct mailing versus GP-preselection Bak, Annette
1996
17 2S1 p. S46-
1 p.
artikel
57 A86 Potential effects of slower than expected recruitment and proposed changes in eligibility criteria on power in a randomized controlled trial Wright, Elizabeth C.
1996
17 2S1 p. S88-
1 p.
artikel
58 A65 Procedures for handling criticism and comments from study investigators Gordon, Mae
1996
17 2S1 p. S76-
1 p.
artikel
59 A38 Proportional hazards model for assessing visual acuity data Wisniewski, Stephen R.
1996
17 2S1 p. S60-
1 p.
artikel
60 A33 Quality management of a multicenter selective lymphadenectomy trial (MSLT): A model for success Flaherty, Sandra
1996
17 2S1 p. S57-
1 p.
artikel
61 A88 Randomization to pharmacologic andbehavioral therapy separately within the same study and blinding issues Cnaan, Avital
1996
17 2S1 p. S89-
1 p.
artikel
62 A14 Recruitment for a large-scale clinical study via the internet Zadnik, K.
1996
17 2S1 p. S45-
1 p.
artikel
63 A16 Recruitment to breast cancer clinical trials Morrill, Allison C.
1996
17 2S1 p. S46-S47
2 p.
artikel
64 A68 Results of rekey verification at the clinical centers in the hemodialysis (HEMO) study Gassman, Jennifer
1996
17 2S1 p. S77-S78
2 p.
artikel
65 A48 Rigorous end point assessment procedures in reducing bias Nelson, J.J.
1996
17 2S1 p. S66-
1 p.
artikel
66 A01 Samples sizes for phase II trials in multiple sclerosis Schwid, Steven R.
1996
17 2S1 p. S38-
1 p.
artikel
67 A60 Stopping a clinical trial very early based on sequential conditional probability ratio test Ming, Tan
1996
17 2S1 p. S72-S73
2 p.
artikel
68 A44 Strategies for including costs in randomized controlled trials of new medical technologies: The implementation of an economic analysis of an aicd (Automatic Implantable Cardiac Defibrillator) Gajary, Elizabeth
1996
17 2S1 p. S63-S64
2 p.
artikel
69 A04 Survey of collaborators' opinions about study results Weston, Julie
1996
17 2S1 p. S39-
1 p.
artikel
70 A27 Teaching the next generation of clinical trialists Kelsey, Sheryl F.
1996
17 2S1 p. S53-S54
2 p.
artikel
71 A45 Team managed hospital based home care: Design of a multi-site randomized trial Weaver, Frances
1996
17 2S1 p. S64-
1 p.
artikel
72 A18 Technical and architectural problems and solutions associated with registers of clinical trials Strang, Nigel
1996
17 2S1 p. S48-
1 p.
artikel
73 A06 Termprom investigator survey Hewson, Sheila
1996
17 2S1 p. S40-S41
2 p.
artikel
74 A76 The impact of method of calculation of electronically monitored adherence data Rohay, Jeffrey M.
1996
17 2S1 p. S82-S83
2 p.
artikel
75 A87 The impact of using different albumin laboratory methods on eligibility in the HEMO study Beck, Gerald
1996
17 2S1 p. S89-
1 p.
artikel
76 A82 The importance of the design of a pilot study providing the most exhaustive data for the protocol of a large controlled clinical trial Gardinle, E.
1996
17 2S1 p. S86-
1 p.
artikel
77 A25 The prognostic profile of the patients is essential for any comparative interpretation of clinical trials Hasford, J.
1996
17 2S1 p. S52-
1 p.
artikel
78 A56 Three gigabytes of transcranial doppler readings: Logistics of blinding the central readers and quality assurance in a 12 center clinical trial Tighe, Foss
1996
17 2S1 p. S70-S71
2 p.
artikel
79 A85 Tools for the visualization of patient accrual trends in clinical trials Buzydlowski, Jan W.
1996
17 2S1 p. S88-
1 p.
artikel
80 A19 Tracking monitoring activities performed at the Coordinating Center Doherty, Irene
1996
17 2S1 p. S48-S49
2 p.
artikel
81 A07 Training and quality control procedures for remote database management of 24 hour dietary recalls Doroshenko, Linda
1996
17 2S1 p. S41-
1 p.
artikel
82 A05 Treatment guesses by patients and investigators in a double-blind clinical trial Barton, F.
1996
17 2S1 p. S40-
1 p.
artikel
83 A57 Use of a registry as control data: Data management issues in combining existing data into an existing registry Kennard, Elizabeth D.
1996
17 2S1 p. S71-
1 p.
artikel
84 A53 Use of oracle with an interactive voice response system (IVR) to randomize patients in an acute controlled clinical trial McPherson, Joseph A.
1996
17 2S1 p. S69-
1 p.
artikel
85 Author index 1996
17 2S1 p. S139-S154
16 p.
artikel
86 A51 Verification of endpoints in a phase 3 HIV clinical trial Ingraham, Peter
1996
17 2S1 p. S68-
1 p.
artikel
87 A54 Window based data management system for clinical trials Boardman, Chris
1996
17 2S1 p. S69-
1 p.
artikel
88 Calendar of program 1996
17 2S1 p. S3-S35
33 p.
artikel
89 Letter from the President 1996
17 2S1 p. S1-
1 p.
artikel
90 P45 Accessing data from external centralized sources to enhance analysis of a completed clinical trial Abdellatif, Mazen
1996
17 2S1 p. S118-S119
2 p.
artikel
91 P59 A comparison of quantitative computerized and human panel coronary end point measures: Implications for angiographic trial design Dunn, Meleana E.
1996
17 2S1 p. S128-
1 p.
artikel
92 P36 A comparison of statistical methodologies for the calculation of lytic units derived from the modeling of natural killer cells Johnson, Paul
1996
17 2S1 p. S113-
1 p.
artikel
93 P07 A completely automated interactive data management system Othman, Raslan
1996
17 2S1 p. S94-S95
2 p.
artikel
94 P05 Adapting management techniques after conversion to an onsite, interactive data management system (IDMS) Ellis, Nancy
1996
17 2S1 p. S93-S94
2 p.
artikel
95 P64 Adverse medical events reported by patients in control groups Raisch, Dennis W.
1996
17 2S1 p. S131-
1 p.
artikel
96 P37 A mixed models approach to the analysis of the treatment of delayed onset muscle soreness Golloso-Nagpala, Fides R.
1996
17 2S1 p. S113-S114
2 p.
artikel
97 P53 An approximation of kappa's variance Pintilie, Melania
1996
17 2S1 p. S124-S125
2 p.
artikel
98 P72 An iterative process for defining nonfatal endpoints in the context of clinical trials Tardiff, Barbara E.
1996
17 2S1 p. S136-
1 p.
artikel
99 P33 Antidepressant evaluation: Methodological considerations for meta-analysis Cialdella, Philippe
1996
17 2S1 p. S111-
1 p.
artikel
100 P09 A pilot study for feasibility of long-term patient follow-up after the end of a clinical trial Beck, Gerald
1996
17 2S1 p. S95-S96
2 p.
artikel
101 P39 A quality control method for single-data entry using remote data entry systems in large compassionate clinical trials Sharma, Inder J.
1996
17 2S1 p. S115-
1 p.
artikel
102 P15 Are specific trials needed to assess the best treatment duration? Examples in cardiovascular field Gueyffier, François
1996
17 2S1 p. S99-S100
2 p.
artikel
103 P32 A SAS macro for exploratory data analysis using a Bayesian Belief Network Clarke, Ellis
1996
17 2S1 p. S110-
1 p.
artikel
104 P56 Assessment and reorganization of educational training programs developed for data managers Edelman, Bonnie
1996
17 2S1 p. S126-
1 p.
artikel
105 P48 Auditing and verification of clinical data: A coordinating center's role Randall, A.M.Y.
1996
17 2S1 p. S121-
1 p.
artikel
106 P06 Automated edit system from data entry to site notification Harrison, Merrie Jean
1996
17 2S1 p. S94-
1 p.
artikel
107 P52 Can the forest plot be simplified without loosing relevant information in meta-analyses? Bijnens, Luc
1996
17 2S1 p. S124-
1 p.
artikel
108 P30 Challenges in recruiting normal volunteers for clinical trials Herr, Barbara
1996
17 2S1 p. S109-
1 p.
artikel
109 P49 Combining graphical and tabular displays in data monitoring reports Van Natta, Mark L.
1996
17 2S1 p. S121-S122
2 p.
artikel
110 P46 Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally Donfield, Sharyne
1996
17 2S1 p. S119-
1 p.
artikel
111 P73 Comparison of investigator and central events review of myocardial infarction rates as a means to improve events classification: Results from GUSTO-IIa Mahaffey, Kenneth W.
1996
17 2S1 p. S136-S137
2 p.
artikel
112 P51 Concordance of medication adherence measures in primary Raynaud's disease Schlenk, Elizabeth A.
1996
17 2S1 p. S123-
1 p.
artikel
113 P04 Consistency checks in a multi-centered clinical study Konig, Victoria
1996
17 2S1 p. S93-
1 p.
artikel
114 P47 Data management for a Phase III international collaborative study (AIDS clinical trial group study 204/Glaxo Wellcome protocol 123-014) Fry, J.
1996
17 2S1 p. S120-
1 p.
artikel
115 P69 Does workspace effect coordinator performance in a randomized clinical trial? Manos, Kelly S.
1996
17 2S1 p. S134-
1 p.
artikel
116 P03 Dose titration in the multicenter study of hydroxyurea in sickle cell anemia (MSH) Handy, C.
1996
17 2S1 p. S92-
1 p.
artikel
117 P54 Drug packaging challenges in a multicenter trial on opiate dependence Johnson, Elaine L.
1996
17 2S1 p. S125-
1 p.
artikel
118 P08 Edit check: An easy way to clean clinical studies databases Charpentier, B.
1996
17 2S1 p. S95-
1 p.
artikel
119 P12 Efforts to assess subject participation Clerici, Annette M.
1996
17 2S1 p. S97-S98
2 p.
artikel
120 P13 Efforts to enhance participation in a low socio-economic status population Clerici, Annette M.
1996
17 2S1 p. S98-
1 p.
artikel
121 P28 How to achieve successful site participation in a large simple trial Egan, Debra
1996
17 2S1 p. S108-
1 p.
artikel
122 P71 Impact of the clinical events committee process on data safety monitoring Tardiff, Barbara E.
1996
17 2S1 p. S135-
1 p.
artikel
123 P63 Informed consent issues when including genetic testing in clinical trials Schafer, Kimberly
1996
17 2S1 p. S130-S131
2 p.
artikel
124 P58 Intention to treat analysis and the need for supplemental approaches for some trial designs Panzarella, Tony
1996
17 2S1 p. S127-S128
2 p.
artikel
125 P42 Logistics of interim mortality ascertainment Crow, Sharon W.
1996
17 2S1 p. S116-S117
2 p.
artikel
126 P57 Longitudinal variability of ultrasonographic measurements of carotid intimal-medial thickness: Results for ACAPS Craven, Timothy
1996
17 2S1 p. S127-
1 p.
artikel
127 P35 Methodological issues in evaluating graft materials for lumbar spinal fusion Block, Jon E.
1996
17 2S1 p. S112-
1 p.
artikel
128 P50 Minimization technologies in randomized open intervention studies Weverling, Gerrit J.
1996
17 2S1 p. S122-S123
2 p.
artikel
129 P26 Monitoring in a large multicentre international clinical trial: The italian experience in core study Bonfanti, E.
1996
17 2S1 p. S106-S107
2 p.
artikel
130 P11 Monitoring item bias within the SF-36: A bias toward decreased health perception Wasser, Thomas
1996
17 2S1 p. S97-
1 p.
artikel
131 P17 Multicenter trials and cohort studies — valuable resources for long term studies of disease outcomes Wright, Elizabeth
1996
17 2S1 p. S101-
1 p.
artikel
132 P62 On-site monitoring of a multicenter clinical trial: Perspectives from the administrative center, data coordinating center, clinical centers, auditors. And the funding agency Howard, Virginia J.
1996
17 2S1 p. S130-
1 p.
artikel
133 P14 Outcomes of a placebo run-in period in a cancer chemoprevention trial Hudmon, Karen Suchanek
1996
17 2S1 p. S99-
1 p.
artikel
134 P20 Participant perception of the role and benefits of study coordinators: Results of a pilot study Mitchell, Jayne
1996
17 2S1 p. S103-
1 p.
artikel
135 P27 Predictors of missed follow-up interviews in a study of asthma among inner-city children Islam, Shaheen U.
1996
17 2S1 p. S107-
1 p.
artikel
136 P68 Primary outcome verification in a multicenter clinical trial Das, Anita
1996
17 2S1 p. S133-S134
2 p.
artikel
137 P29 Prognostic significance of cardiac enzyme elevations detected through systematic screening in clinical trials Tardiff, Barbara E.
1996
17 2S1 p. S108-S109
2 p.
artikel
138 P34 Proposed strategy for identifying the treatment target population Gueyffier, François
1996
17 2S1 p. S111-S112
2 p.
artikel
139 P18 Prospective case-control studies,following a large multicentre clinical trial: GISSI-2 Bonfanti, E.
1996
17 2S1 p. S101-S102
2 p.
artikel
140 P43 Quality assurance in a multicenter/multidisciplinary clinical trial — A model for a limited budget Stern, Stacey
1996
17 2S1 p. S117-
1 p.
artikel
141 P74 Quality of life (QL) as an outcome measure in the assessment of nausea (N) and vomiting (V) Pater, J.L.
1996
17 2S1 p. S137-
1 p.
artikel
142 P01 Randomization systems in an international multicentre clinical trial: The CORE study Santoro, E.
1996
17 2S1 p. S91-
1 p.
artikel
143 P22 Randomized and non-randomized patients in large clinical trials: The case of GISSI Franzosi, M.G.
1996
17 2S1 p. S104-
1 p.
artikel
144 P70 Recruitment of study sites for participation in a proposed clinical trial Hewson, Sheila
1996
17 2S1 p. S135-
1 p.
artikel
145 P02 Reducing variations in care in the acute myocardial infarction (AMI) patient using medical practice guidelines Reed III, James F.
1996
17 2S1 p. S91-S92
2 p.
artikel
146 P31 Reliability of economic and quality of life data for collection of follow-up clinical outcome information Tardiff, Barbara E.
1996
17 2S1 p. S110-
1 p.
artikel
147 P25 Representativeness of clinical trial participants: The hemodialysis study Kusek, John W.
1996
17 2S1 p. S106-
1 p.
artikel
148 P67 Social factors influence dietary satisfaction in the modification of diet in renal disease study Olson, Marian
1996
17 2S1 p. S133-
1 p.
artikel
149 P60 Standardizing data collection by interviewers on a multi-site longitudinal research study Fischbach, Heidi E.
1996
17 2S1 p. S128-S129
2 p.
artikel
150 P21 Steps in the development of a disease-specific quality of life measure Fink, Nancy
1996
17 2S1 p. S103-S104
2 p.
artikel
151 P38 System for monitoring timing of data review and entry: A tool for internal data quality control Zee, Benny
1996
17 2S1 p. S114-
1 p.
artikel
152 P16 Tailoring interventions for children in the inner-city Mitchell, Herman E.
1996
17 2S1 p. S100-S101
2 p.
artikel
153 P61 The application of pharmacokinetic modeling to the predication of drug needs during multicenter clinical trials Barnhill, Jamie G.
1996
17 2S1 p. S129-
1 p.
artikel
154 P40 The design of a windows-based cati software system Goldstein, Robert B.
1996
17 2S1 p. S115-S116
2 p.
artikel
155 P10 The efficacy of testosterone treatment in HIV-related wasting: Does testosteronereplacement help? Cofrancesco Jr., Joseph
1996
17 2S1 p. S96-
1 p.
artikel
156 P65 The impact of early closure of a clinical trial on a related study Cloud, Gretchen
1996
17 2S1 p. S131-S132
2 p.
artikel
157 P23 The role of a regional data coordinating centre (RDCC) in a multi-national large phase-II trial Franzosi, M.G.
1996
17 2S1 p. S104-S105
2 p.
artikel
158 P55 Treatment discontinuation in a Phase III cytomegalovirus prophylaxis trial: Design and analysis Hurwitz, Shelley
1996
17 2S1 p. S125-S126
2 p.
artikel
159 P24 Tunnel vision: A flaw to avoid when preparing study materials Liu, Margaret B.
1996
17 2S1 p. S105-
1 p.
artikel
160 P44 Using SAS and wordperfect to automate the production of study data tables Horney, R.Anne
1996
17 2S1 p. S118-
1 p.
artikel
161 P66 Variables associated with successful site performance in a large, randomized, chronic heart failure trial Rendall, David
1996
17 2S1 p. S132-
1 p.
artikel
162 P41 Weeding out bad apples: Monitoring data quality in RCTs Flann, M.A.
1996
17 2S1 p. S116-
1 p.
artikel
163 P19 Why do patients accept or decline randomization? Rajab, Mohammad Hasan
1996
17 2S1 p. S102-
1 p.
artikel
164 S11 Internal estimation of the sample size for a t-test Denne, Jonathan S.
1996
17 2S1 p. S43-
1 p.
artikel
165 S10 Planning clinical trials to evaluate early detection programs Hu, Ping
1996
17 2S1 p. S43-
1 p.
artikel
166 S12 Standardized computer-based reporting of clinical trials: In support of meta-analysis Sim, Ida
1996
17 2S1 p. S44-
1 p.
artikel
                             166 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland